Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,720 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,363
Recruiting: 3,965
Ph III recruiting: 535
Growth YoY: +10.3%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,404)

clinicaltrialsPublishedShowing 2,601–2,619 of 2,619 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00263016	Docetaxel in Non Small Cell Lung Cancer (NSCLC)	terminated	Phase 2	50	SanofiINDUSTRY	1	Mar 20, 2008	clinicaltrials
NCT00417677	A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma	terminated	Phase 1 / Phase 2	124	Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY	1	Dec 28, 2007	clinicaltrials